Skip to main content
Log in

Summary

Tumors are believed to consist of a heterogeneous population of tumor cells originating from rare cancer stem cells (CSCs). However, emerging evidence suggests that tumor may also originate from non-CSCs. To support this viewpoint, we are here to present definitive evidence indicating that the number of tumorigenic tumor cells is greater than that of CSCs in tumor, and tumor can also derive from non-CSCs. To achieve this, an idealized mathematical model was employed in the present study and theoretical calculation revealed that non-CSCs could initiate the occurrence of tumor if their proliferation potential was adequate. Further, experimental studies demonstrated that 17.7%, 38.6% and 5.2% of tumor cells in murine B16 solid melanoma, H22 hepatoma and Lewis lung carcinoma, respectively, were potentially tumorigenic. Thus, based on the aforementioned findings, we propose that the scarce CSCs, if exist, are not the sole source of a tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003,3(12):895–902

    Article  PubMed  CAS  Google Scholar 

  2. Bjerkvig R, Tysnes BB, Aboody KS, et al. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer, 2005,5(11):899–904

    Article  PubMed  CAS  Google Scholar 

  3. Rosen JM, Jordan CT. The increasing complexity of the cancer stem cell paradigm. Science, 2009,324(5935): 1670–1673

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Smith A. A glossary for stem-cell biology. Nature, 2006, 441(7097):1060–1060

    Article  CAS  Google Scholar 

  5. O’Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007,445(7123):106–110

    Article  PubMed  Google Scholar 

  6. Maccalli C, Volontè A, Cimminiello C, et al. Immunology of cancer stem cells in solid tumours. A review. Eur J Cancer, 2014,50(6):649–55

    Article  CAS  Google Scholar 

  7. Sourisseau T, Hassan KA, Wistuba I, et al. Lung cancer stem cell: fancy conceptual model of tumor biology or cornerstone of a forthcoming therapeutic breakthrough? J Thorac Oncol, 2014,9(1):7–17

    Article  PubMed  Google Scholar 

  8. Yamashita T, Wang XW. Cancer stem cells in the development of liver cancer. J Clin Invest, 2013, 123(5):1911–1918

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Nishikawa S, Dewi DL, Ishii H, et al. Transcriptomic study of dormant gastrointestinal cancer stem cells. Int J Oncol, 2012,41(3): 979–984

    PubMed  CAS  Google Scholar 

  10. Kelly PN, Dakic A, Adams JM, et al. Tumor growth need not be driven by rare cae]s. Science, 2007,317e](5836): 337

    Article  Google Scholar 

  11. Quintana E, Shackleton M, Sabel MS, et al. Efficient tumour formation by single human melanoma cells. Nature, 2008,456(7222):593–598

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. He YF, Liu YK, Lu HJ, et al. Comparative proteomic analysis of primary mouse liver c-Kit-(CD45/TER119)-stem/progenitor cells. J Cell Biochem, 2007,102(4): 936–946

    Article  PubMed  CAS  Google Scholar 

  13. He YF, Zhang GM, Wang XH, et al. Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine. J Immunol, 2004,173(9):4919–4928

    Article  PubMed  CAS  Google Scholar 

  14. Collani E, Dräger K. Binomial distribution handbook for scientists and engineers. Birkhauser Boston Press, 2001, Boston.

    Book  Google Scholar 

  15. Enderling H, Hlatky L, Hahnfeldt P. Migration rules: tumours are conglomerates of self-metastases. Br J Cancer, 2009,100(12):1917–1925

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Roose T, Netti PA, Munn LL, et al. Solid stress generated by spheroid growth estimated using a linear poroelasticity model small star, filled. Microvasc Res, 2003,66(3): 204–212

    Article  PubMed  Google Scholar 

  17. Al-Hajj M1, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A, 2003,100(7):3983–3988

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Adams JM, Kelly PN, Dakic A, et al. Response to comment on “tumor growth need not be driven by rare cancer stem cells”. Science, 2007,318(5857):1722

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yu-fei He  (贺宇飞).

Additional information

This project was supported by Scientific Research Fund of Shanghai Health Bureau of China (No. 2008131).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, M., Xiang, Fx. & He, Yf. Are cancer stem cells the sole source of tumor?. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 34, 621–625 (2014). https://doi.org/10.1007/s11596-014-1327-8

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-014-1327-8

Key words

Navigation